New Drugs for Heart Failure


December 4th, 2015 - December 4th, 2018
1.00 AMA PRA Category 1 Credit Hours

Description

Today on MedNet21, we're going to discuss New Drugs for Heart Failure.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 12/4/2018

Objectives

As a result of this educational activity, webcast participants will be able to: Provide an OVERVIEW of the primary prevention strategies of sudden cardiac death in chronic systolic heart failure; and DESCRIBE the role of new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

Webcasts Files

File Link

New Drugs for Heart Failure - 2

Download

New Drugs for Heart Failure - 4

Download

Disclosure Information for Planning Committee Members and Speakers

Download

Speakers

  • Dr. James Allen, MD
    • New Drugs for Heart Failure
  • Dr. Rami Kahwash, MD
    • New Drugs for Heart Failure
  • Dr. Brent Lampert, DO
    • New Drugs for Heart Failure

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.